ARCH Venture Fund IX L.P. 13D and 13G filings for Boundless Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-10-29 6:32 pm Purchase | 2024-04-02 | 13D | Boundless Bio, Inc. BOLD | ARCH Venture Fund IX L.P. | 2,699,970 12.100% | 2,699,970![]() (New Position) | Filing |